C12N 2710/12011
Asfarviridae
C12N2710/12011 (Asfarviridae) appears on 36 US grants and 76 published applications in this corpus.
Search patents in C12N- Granted patents
- 36
- Published applications
- 76
- Assignees
- 54
- Inventors
- 233
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 3 |
| 2009 | 0 | 0 |
| 2010 | 1 | 3 |
| 2011 | 1 | 0 |
| 2012 | 0 | 2 |
| 2013 | 2 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 1 |
| 2016 | 3 | 2 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 4 |
| 2021 | 4 | 4 |
| 2022 | 1 | 13 |
| 2023 | 7 | 15 |
| 2024 | 5 | 12 |
| 2025 | 3 | 9 |
| 2026 | 4 | 3 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2710/12034Use of virus or viral component as vaccineIndexing code21
- C12N 2710/12022New viral proteins or individual genes, new structural or functional aspects ofIndexing code18
- C12N 2710/12021Viruses as suchIndexing code9
- C12N 2710/12051Methods of production or purification of viral materialIndexing code8
- C12N 2710/12061Methods of inactivation or attenuationIndexing code5
- C12N 2710/12071Demonstrated in vivo effectIndexing code5
- C12N 2710/12041Use of virus, viral particle or viral elements as a vectorIndexing code2
- C12N 2710/12023Virus like particles [vlp]Indexing code1
All 12 subgroupsShow fewer
Recent patents
- African swine fever DIVA immunoassay18 Aug 2026US 12,710,423 B2Intervet Inc.
- Recombinant adenovirus expressing African swine fever virus EP153R-EP402R protein and construction method thereof5 May 2026US 12,618,083 B2Institute of Animal Sciences of Chinese Academy of Agricultural Sciences
- Methods for growing African swine fever virus in fetal porcine lung alveolar macrophage cells21 Apr 2026US 12,606,803 B2
- African swine fever virus chimeric protein, vaccine composition, preparation method and use thereof17 Feb 2026US 12,551,545 B2Pulike Biological Engineering, Inc.
- African swine fever virus vaccine4 Nov 2025US 12,458,690 B2Stichting Wageningen Research
- Vaccines against african swine fever virus, and methods of using same8 Oct 2026US 2026/0306608 A1The Wistar Institute of Anatomy and Biology
- A vaccine for protecting a pregnant swine against african swine fever3 Sep 2026US 2026/0256902 A1Intervet Inc.
- Seven-component antigen african swine fever subunit vaccine7 May 2026US 2026/0124289 A1Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Dual-promoter recombinant vector expressing immunogenic protein of african swine fever virus (asfv), recombinant bacterium, and use thereof11 Dec 2025US 2025/0375513 A1Changsha Lvye Biotechnology Co., Ltd.
- Pathogen-like antigen-based vaccine and preparation method therefor2 Oct 2025US 2025/0302940 A1Institute of Biophysics, Chinese Academy of Sciences
Most cited
By later US patents
- Cellular permissivity factor for viruses and uses thereof7US 7,754,464 B2Pharmacia & Upjohn Company · 2010
- Cellular permissivity factor for viruses and uses thereof7US 8,058,050 B2Pharmacia & Upjohn Company · 2011
- Cellular permissivity factor for viruses and uses thereof5US 9,102,912 B2Zoetis Services LLC · 2015
- Rationally developed african swine fever attenuated virus strain protects against challenge with parental virus georgia 2007 isolate5US 9,808,520 B1The United States of America as represented by the Secretary of Agriculture · 2017
- Preventive and therapeutic use of polypeptides from African Swine virus as vaccines3US 7,396,531 B22008